These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35087132)

  • 21. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.
    Wang Y; Sakaguchi M; Sabit H; Tamai S; Ichinose T; Tanaka S; Kinoshita M; Uchida Y; Ohtsuki S; Nakada M
    J Neurosurg; 2023 Mar; 138(3):639-648. PubMed ID: 35932265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma.
    Guo T; Wu C; Zhang J; Yu J; Li G; Jiang H; Zhang X; Yu R; Liu X
    Cell Commun Signal; 2023 Dec; 21(1):363. PubMed ID: 38115126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures.
    Daniel PM; Filiz G; Tymms MJ; Ramsay RG; Kaye AH; Stylli SS; Mantamadiotis T
    Exp Mol Pathol; 2018 Aug; 105(1):23-31. PubMed ID: 29852183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive glioblastoma cells acquire stemness and increased Akt activation.
    Molina JR; Hayashi Y; Stephens C; Georgescu MM
    Neoplasia; 2010 Jun; 12(6):453-63. PubMed ID: 20563248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
    Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
    Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling.
    Wang GP; Han XF
    Mol Med Rep; 2015 Jul; 12(1):1381-6. PubMed ID: 25760022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
    Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
    Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
    Front Immunol; 2021; 12():637053. PubMed ID: 34108959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of HLA-II related to LAG-3
    Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
    Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma.
    Somasundaram A; Ardanowski N; Opalak CF; Fillmore HL; Chidambaram A; Broaddus WC
    Neurosurg Focus; 2014 Dec; 37(6):E14. PubMed ID: 25434383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
    Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
    Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.
    Ward Y; Lake R; Martin PL; Killian K; Salerno P; Wang T; Meltzer P; Merino M; Cheng SY; Santoro M; Garcia-Rostan G; Kelly K
    Oncogene; 2013 May; 32(22):2726-38. PubMed ID: 22797060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
    Dumas AA; Pomella N; Rosser G; Guglielmi L; Vinel C; Millner TO; Rees J; Aley N; Sheer D; Wei J; Marisetty A; Heimberger AB; Bowman RL; Brandner S; Joyce JA; Marino S
    EMBO J; 2020 Aug; 39(15):e103790. PubMed ID: 32567735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.